Search clinical trials for: Bivalent oral polio vaccine

Total 27163 results

PATH
Bio Farma, Indonesia

Not yet recruiting

Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines

Poliomyelitis

Bangladesh
Sanofi Pasteur, a Sanofi Company

Recruiting

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa (MEQ00064)

Healthy Volunteers | Meningococcal Immunisation

South Africa, India
Centers for Disease Control and Prevention
International Centre for Diarrhoeal Disease Research, Bangladesh

Completed

Immunogenicity nOPV2 With and Without bOPV

Poliomyelitis

Bangladesh
PATH

Completed

Inactivated Poliovirus Vaccine (IPV) With or Without E.Coli Double Mutant Heat-Labile Toxin (dmLT) Challenge Study in Healthy Adults

Polio

Belgium
Fidec Corporation
Bill and Melinda Gates Foundation

Withdrawn

Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine

Poliomyelitis
Centers for Disease Control and Prevention
International Centre for Diarrhoeal Disease Research, Bangladesh

Completed

Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity Study (mOPV1)

Poliomyelitis

Bangladesh
Centers for Disease Control and Prevention
International Centre for Diarrhoeal Disease Research, Bangladesh

Completed

Duration of IPV Priming and Antibody Decay

Poliomyelitis

Bangladesh
PATH
Beijing Bio-Institute Biological Products Co., Ltd., formerly Beijing TiantanBio

Completed

Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine

Poliomyelitis

Kenya
PT Bio Farma

Completed

Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV

Healthy

Indonesia
Guangxi Zhuang Autonomous Region Center for Disease...
Air Force Military Medical University, China; Beijing Tiantan Biological Products...

Completed

Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine (TTbOPV)

Poliomyelitis
Centers for Disease Control and Prevention
Tribhuvan University, Nepal

Completed

Diarrhea and Bivalent Oral Polio Vaccine Immunity

Diarrhea | Polio | Seroimmunity

Nepal
Fidec Corporation
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention

Completed

Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine

Poliomyelitis

Colombia, Dominican Republic, Guatemala, Panama
Aga Khan University
World Health Organization

Completed

Pakistan Short Interval mOPV1 Compared With Standard Interval mOPV1 and bOPV 1,3 (SIAD)

Polio

Pakistan
Aga Khan University
National Institutes of Health (NIH); World Health Organization

Completed

IPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi. (MIPV)

Immunity to Polio Vaccines in Malnourished Infants | Immunity to Polio Vaccines in Non-malnourished Infants

Pakistan
Centers for Disease Control and Prevention
International Centre for Diarrhoeal Disease Research, Bangladesh; Ministry... and other collaborators

Completed

Immunogenicity of Inactivated and Live Polio Vaccines

Poliomyelitis

Bangladesh
International Centre for Diarrhoeal Disease Research...

Completed

Poliovirus Vaccine Trial in Bangladesh

Healthy Infants

Bangladesh
International Centre for Diarrhoeal Disease Research...
Centers for Disease Control and Prevention; Government of Bangladesh

Not yet recruiting

Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV

Polio
PATH
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; PT Bio Farma and other collaborators

Recruiting

Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama

Poliomyelitis

Panama
PATH
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; PT Bio Farma and other collaborators

Recruiting

Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh

Poliomyelitis

Bangladesh
LG Chem

Recruiting

Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in Infants

Vaccine Reaction | Poliomyelitis

Philippines
University of Oxford
Malaria Research and Training Center, Bamako, Mali

Recruiting

Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines

Malaria

Mali, United Kingdom
International Centre for Diarrhoeal Disease Research...
Stanford University; Centers for Disease Control and Prevention

Recruiting

Immunogenicity of Co-administered Oral Polio Vaccine and Oral Cholera Vaccine

Vaccine Reaction

Bangladesh
Bandim Health Project
Radboud University Medical Center

Enrolling by invitation

The Non-Specific Immunological Effects of Providing Oral Polio Vaccine to Seniors in Guinea-Bissau

Vaccine Reaction

Guinea-Bissau
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine

Poliomyelitis

Panama
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Healthy Volunteers (Meningococcal Infection)

United States, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Pertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Pneumococcal Immunisation | Hepatitis B Immunisation | Haemophilus Influenzae Type b Immunisation | Polio Immunisation | Measles Immunisation | Rubella Immunisation | Varicella Immunisation | Mumps Immunisation

United States, Canada, Honduras, Puerto Rico
University of Vermont
World Health Organization

Active, not recruiting

Intradermal Fractional Dose IPV (fIPV) in Combination With dmLT

Poliomyelitis

United States
Celal Bayar University

Completed

Effect of OMEGA 3 Fatty Acids on Lactation Period

Lactation Induced

Turkey
Institute of Medical Biology, Chinese Academy of...
Guangxi Center for Disease Control and Prevention

Completed

The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)

Poliomyelitis

China
Istari Oncology, Inc.
National Cancer Institute (NCI); Duke University; Brain Tumor Research Charity...

Completed

PVSRIPO for Recurrent Glioblastoma (GBM) (PVSRIPO)

Glioma | Glioblastoma | Malignant Glioma | GBM

United States
Memorial Sloan Kettering Cancer Center
Y-mAbs Therapeutics

Active, not recruiting

Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma

Neuroblastoma

United States
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age (T2-ABMG)

Poliomyelitis
PATH
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; The Emmes Company, LLC and other collaborators

Completed

Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines

Poliomyelitis

United States
International Centre for Diarrhoeal Disease Research...
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; PA... and other collaborators

Completed

Clinical Trial of Novel OPV2 Vaccine

Poliomyelitis

Bangladesh
Sanofi Pasteur, a Sanofi Company

Completed

Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand

Pertussis Immunisation | Diphtheria Immunisation | Tetanus Immunisation | Pneumococcal Immunisation | Hepatitis B Immunisation | Polio Immunisation | Haemophilus Influenzae Type B Immunisation | Rotavirus Immunisation

Thailand
Bandim Health Project

Active, not recruiting

OPV as Potential Protection Against COVID-19

Mortality | COVID | Morbidity | Poliovirus Vaccine, Oral | Non-Specific Effects of Vaccines

Guinea-Bissau
Pierre Van Damme
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; PA... and other collaborators

Completed

A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates

Poliomyelitis

Belgium
Bandim Health Project
March of Dimes; Danida

Completed

Sex-Differential Health Interventions In Low-Birth-Weight Infants

Mortality | Growth | Morbidity | Neonatal Mortality

Guinea-Bissau
Bandim Health Project
Statens Serum Institut; Research Center for Vitamins and Vaccines

Unknown

Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children (RE-CAMP)

Mortality | Children | Oral Polio Vaccine | Morbidity | Measles Vaccination | Non-specific/Heterologous Effects of Vaccines

Guinea-Bissau
Aga Khan University
World Health Organization

Completed

Effect of Zinc Supplementation on Response to Oral Polio Vaccine in Infants in Pakistan

Poliomyelitis

Pakistan
Aga Khan University
Bill and Melinda Gates Foundation; World Health Organization; UNICEF; Peshawar... and other collaborators

Unknown

To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in Pakistan

Polio | Polio Sero Conversion | Polio Sero Prevalence | Immunization Coverage

Pakistan
Pierre Van Damme
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; PA... and other collaborators

Completed

Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults (nOPV2M4a)

Poliomyelitis

Belgium
GlaxoSmithKline

Completed

This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine

Rotavirus Infection | Rotavirus Vaccines

United States
NeuroActiva, Inc.
Biomed Industries, Inc.

Unknown

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831)

Covid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

New Zealand, United States
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children (M2-ABMG)

Adverse Event Following Immunisation
Aga Khan University
World Health Organization

Unknown

Use of mOPV1 in Routine Immunization in Pakistan. (mOPV1)

Oral Polio Vaccine

Pakistan
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine

Poliomyelitis | Poliomyelitis Vaccines

China
GlaxoSmithKline

Completed

An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africa

Malaria

Burkina Faso, Kenya, Tanzania
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants

Rotavirus

Japan
Universiteit Antwerpen
Chulalongkorn University; Thrasher Research Fund; Institut Pasteur de Lille

Completed

Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand

Pertussis

Thailand

Search clinical trials for: Bivalent oral polio vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations